David S Allan at University of Ottawa - Research Interests, Publications & Academic Profile

David S Allan

University of Ottawa

Canada

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Turkish students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

30%

Tissue Engineering

30%

Hematology

80%

Stem Cell Transplantation

60%

Renal Replacement Therapy

40%

Cell Therapy

40%

Graft-versus-host Disease

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Article Link

Year:

2024

Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies

Article Link

Year:

2024

Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation

Article Link

Year:

2024

Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review

Article Link

Year:

2023

Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia

Article Link

Year:

2023

Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Article Link

Year:

2023

Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups

Article Link

Year:

2023

Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?

Article Link

Year:

2023

Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies

Article Link

Year:

2023

HLA‐haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utility

Article Link

Year:

2023

Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure

Article Link

Year:

2022

Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval

Article Link

Year:

2022

Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis

Article Link

Year:

2022

Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID‐19 pandemic: A Canadian Blood Services Stem Cell Registry analysis

Article Link

Year:

2022

Collaborators6

Mitchell Sabloff

Head of the Leukemia Program

Ottawa Hospital

CANADA

Philip Berardi

Physician/Associate Professor

Ottawa Hospital Research Institute

CANADA

Uday Deotare

Assistant Professor

CANADA

Muhammad Bilal Abid

UNITED STATES

Arjun Law

Assistant Professor

University of Toronto

CANADA

Dylan Burger

Assistant Professor

University of Ottawa

CANADA

How do Turkish students reach out?

Meet Kite AI